[go: up one dir, main page]

CA2048627A1 - 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism - Google Patents

1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism

Info

Publication number
CA2048627A1
CA2048627A1 CA002048627A CA2048627A CA2048627A1 CA 2048627 A1 CA2048627 A1 CA 2048627A1 CA 002048627 A CA002048627 A CA 002048627A CA 2048627 A CA2048627 A CA 2048627A CA 2048627 A1 CA2048627 A1 CA 2048627A1
Authority
CA
Canada
Prior art keywords
hydrogen
formula
group
metal
tetraoxa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002048627A
Other languages
English (en)
French (fr)
Inventor
Jozsef Emri
Bela Gyori
Zoltan Kovacs
Erno Brucher
Laszlo B. Sztanyik
Lazlo Varga
Odon Kiraly
Bela Kanyar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ORSZAGOS "FREDERIC JOLIOT-CURIE" SUGARBIOLOGIAI ES SUGAREGESZSEGUGYI KUTATO INTEZET
Kossuth Lajos Tudomanyegyetem
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2048627A1 publication Critical patent/CA2048627A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/08—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and more than one oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA002048627A 1990-01-16 1990-11-07 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism Abandoned CA2048627A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU90145A HU210667B (hu) 1990-01-16 1990-01-16 Eljárás N,N'-bisz(dikarboxi-metil)-1,4,10,13-tetraoxa-7,16-diaza-ciklooktadekán-származékok sói és komplexei és a vegyületeket tartalmazó gyógyászati készítmények előállítására
HU145/90 1990-01-16

Publications (1)

Publication Number Publication Date
CA2048627A1 true CA2048627A1 (en) 1991-07-17

Family

ID=10948158

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002048627A Abandoned CA2048627A1 (en) 1990-01-16 1990-11-07 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism

Country Status (10)

Country Link
EP (1) EP0463123A1 (uk)
JP (1) JPH04505626A (uk)
KR (1) KR970009042B1 (uk)
AU (1) AU645507B2 (uk)
CA (1) CA2048627A1 (uk)
HU (2) HU210667B (uk)
IN (1) IN171733B (uk)
RU (1) RU2060256C1 (uk)
UA (1) UA35547C2 (uk)
WO (1) WO1991010655A1 (uk)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005804A1 (en) * 1990-09-27 1992-04-16 Brunswick Corporation Chelating agents
HUP1100731A2 (en) * 2011-12-30 2013-06-28 Stratoxer S Kft Complex forming compounds
EA201201241A1 (ru) * 2012-06-19 2013-12-30 Елена Владимировна ОРЛОВА БИОБЕЗОПАСНЫЙ НАНОКОМПОЗИТНЫЙ ПОЛИМЕРНЫЙ СОРБЕНТ ДЛЯ СЕЛЕКТИВНОГО СВЯЗЫВАНИЯ ИЗОТОПОВ Sr И Cs ИЗ ЖИДКИХ СРЕД И СЫРЬЕВАЯ СМЕСЬ ДЛЯ ЕГО ИЗГОТОВЛЕНИЯ

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190462A (en) * 1978-07-04 1980-02-26 Shell Oil Company Dissolving barium sulfate scale with aqueous solutions of salts of carboxymethyl monocyclic macrocyclic polyamines
US4597903A (en) * 1984-08-21 1986-07-01 University Of Maryland Process for the direct preparation of N,N-disubstituted derivatives for 4,13-diaza-18-crown-6
JPS61263964A (ja) * 1985-05-17 1986-11-21 Terumo Corp 新規クラウン（チオ）エ−テルおよびその製造方法

Also Published As

Publication number Publication date
HU900145D0 (en) 1990-03-28
HUT73493A (en) 1996-08-28
UA35547C2 (uk) 2001-04-16
RU2060256C1 (ru) 1996-05-20
AU6711690A (en) 1991-08-05
HU210667B (hu) 1998-03-30
IN171733B (uk) 1992-12-26
KR920701184A (ko) 1992-08-11
EP0463123A1 (en) 1992-01-02
WO1991010655A1 (en) 1991-07-25
KR970009042B1 (ko) 1997-06-03
AU645507B2 (en) 1994-01-20
HU9502769D0 (en) 1995-11-28
JPH04505626A (ja) 1992-10-01

Similar Documents

Publication Publication Date Title
US5624901A (en) 3-hydroxy-2(1H)-pyridinone chelating agents
CA1324150C (en) Paramagnetic chelates useful for nmr imaging
Hegetschweiler A rigid, cyclohexane-based polyamino-polyalcohol as a versatile building block for tailored chelating agents
US4698431A (en) Hydroxypyridonate chelating agents
US5885548A (en) Multiply substituted DTPA derivatives and their metal complexes, and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents
US5039512A (en) NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes
US4442305A (en) Polycatecholamide chelating agents
US4758422A (en) Ferrioxamine paramagnetic contrast agents for MR imaging
EP0452392B1 (en) Heterocyclic chelating agents
EP0198051A1 (en) Gadolinium chelates as nmr contrast agents
US5236695A (en) MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
EP0287465A1 (fr) Ligands cycliques azotés, complexes métalliques formés par ces ligands, compositions de diagnostic contenant ces complexes et procédé de préparation des ligands
DE68927271T2 (de) Chelatbildende Verbindungen die eine orthobindende Gruppe besitzen und ihre Komplexe
EP0840727B1 (en) 3-hydroxy-2(1h)-pyridinone chelating agents
KR19980701674A (ko) 비스무트 화합물
EP0717639A1 (en) Polyamino paramagnetic chelates which contain both phosphonate and non-phosphonate moieties for mri
CA2048627A1 (en) 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism
US5440031A (en) 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from living organism
JPH11501012A (ja) 新規な方法において置換されたｄｔｐａ誘導体、それらの金属錯体、これらの錯体を含有する医薬製剤、診断および治療におけるそれらの使用、ならびに錯体および医薬製剤の製造方法
DE69810492T2 (de) Mehrzähnige imine und ihre metalkomplexe
CA1230342A (en) Tc99m-phenida, radioscintigraphic agent for diagnosis of hepatobiliary disease
US5288718A (en) Method for decorporating radioactive isotope from living organism
RU2072993C1 (ru) Способ получения соли 1, 4, 10, 13-тетраокса-7,16-диазациклооктадекан-n,n'-дималоновой кислоты
HU211923A9 (hu) 1,4,10,13-Tetraoxa-7,16-diaza-ciklooktadekán-származékok, a vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk toxikus fémionok és radioaktív izotópok élő szervezetből történő eltávolítására Az átmeneti oltalom az 1-7. igénypontokra vonatkozik.
DE69621787T2 (de) Polyazacycloalkanverbindungen

Legal Events

Date Code Title Description
FZDE Dead